Terning The Flight To Innovation With Terns Pharma CEO Amy Burroughs

Recorded on 03/02/26 TD Cowen senior biotech analyst Yaron Werber speaks with Amy Burroughs, CEO of Terns Pharmaceuticals, at the 46th Annual TD Cowen Health Care Conference, discussing leadership, resilience, and innovation in biotech. Amy reflects on her non‑linear career path from large organizations to smaller biotechs, and how those experiences shaped her approach to building teams and leading through change. She discusses how Terns, inspired by the agility and persistence of the Arctic tern, evolved through multiple pivots to focus on TERN-701, its lead program in chronic myeloid leukemia (CML). She outlines the key unmet need in CML – the pursuit of functional cures – and explains Terns’ plans to advance TERN‑701 into pivotal trials with urgency and discipline. On a personal note, Amy describes her leadership “superpower”: learning not to be the smartest person in the room, listening intently, and surrounding herself with trusted advisors. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.